Up 36% from IPO price, SMIFS sees another 60% upside in this hospital stock
Domestic brokerage house SMIFS believes Yatharth Hospital and Trauma Care Services is poised for growth with rising occupancy and gains in average Revenue Per Occupied Bed (ARPOB). It has retained its ‘buy’ call on the stock with a target price of ₹650, implying an upside of 60 percent from its current market price of 406.75, … Read more